Roche says US approves Avastin drug to treat cervical cancer
ZURICH (Reuters) - Swiss drugmaker Roche said on Friday the U.S. Food and Drug Administration (FDA) had approved the use of its Avastin cancer drug in combination with chemotherapy to treat advanced cervical cancer.
Avastin has now been approved to treat five distinct tumor types in the United States, Roche said.
(Reporting by Alice Baghdjian)
- Exclusive: Angry with Washington, 1 in 4 Americans open to secession
- Secret Service investigates after man jumps White House fence, reaches doors
- About 60,000 Syrian Kurds flee to Turkey from Islamic State advance |
- U.S. immigration protesters drop U.S. border blockade plan
- California governor rejects bills to help men change diapers